Impact of DESTINY-Breast04 Data in HER2-Low Breast Cancer: How to Implement in Clinical Practice | VuMedi

Dana-Farber Cancer Institute

Impact of DESTINY-Breast04 Data in HER2-Low Breast Cancer: How to Implement in Clinical Practice

By Dana-Farber Cancer Institute FEATURING Paolo Tarantino

By Dana-Farber Cancer Institute FEATURING Paolo Tarantino

942 views

February 7, 2023

0 Comments

Login to view comments. Click here to Login